Geneva Capital Management’s BioLife Solutions BLFS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.1M	Sell	739,803 -63,735	-8%	-$1.41M	0.3%	78
2025 Q4	$19.4M	Sell	803,538 -95,493	-11%	-$2.5M	0.37%	76
2025 Q3	$22.9M	Sell	899,031 -2,733	-0.3%	-$64.8K	0.39%	72
2025 Q2	$19.4M	Buy	901,764 +49,637	+6%	+$1.12M	0.33%	77
2025 Q1	$19.5M	Sell	852,127 -614	-0.1%	-$16.2K	0.36%	75
2024 Q4	$22.1M	Sell	852,741 -12,525	-1%	-$312K	0.38%	74
2024 Q3	$21.7M	Buy	865,266 +965	+0.1%	+$22.8K	0.36%	83
2024 Q2	$18.5M	Sell	864,301 -15,914	-2%	-$309K	0.34%	81
2024 Q1	$16.3M	Buy	880,215 +5,730	+0.7%	+$100K	0.29%	88
2023 Q4	$14.2M	Sell	874,485 -650,906	-43%	-$8.3M	0.27%	89
2023 Q3	$21.1M	Sell	1,525,391 -36,052	-2%	-$568K	0.44%	73
2023 Q2	$34.5M	Buy	1,561,443 +2,750	+0.2%	+$57.9K	0.68%	54
2023 Q1	$33.9M	Buy	1,558,693 +38,640	+3%	+$869K	0.69%	54
2022 Q4	$27.7M	Sell	1,520,053 -17,583	-1%	-$363K	0.62%	58
2022 Q3	$35M	Buy	1,537,636 +84,435	+6%	+$1.81M	0.81%	50
2022 Q2	$20.1M	Sell	1,453,201 -3,455	-0.2%	-$50.7K	0.46%	84
2022 Q1	$33.1M	Sell	1,456,656 -32,348	-2%	-$852K	0.64%	65
2021 Q4	$55.5M	Buy	1,489,004 +177,875	+14%	+$7.63M	0.89%	44
2021 Q3	$55.5M	Buy	1,311,129 +284,432	+28%	+$13.7M	0.94%	41
2021 Q2	$45.7M	Sell	1,026,697 -6,398	-0.6%	-$225K	0.74%	60
2021 Q1	$37.2M	Buy	+1,033,095	New	+$40.8M	0.63%	67